Tuesday turned out to be a nightmare for shareholders of Trinity Biotech plc (ADR)(NASDAQ:TRIB), after the company announced that it is withdrawing its 510(k) …
Every investor knows the feeling of wondering what to do when a stock they have invested in falls unexpectedly in value. Although …
In a research report issued yesterday, Roth Capital analyst Chris Lewis reiterated a Buy rating on Trinity Biotech (NASDAQ:TRIB) and reduced his price …